Evidence map›Paper›PMID 35884138›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Aminoglycoside-Modifying Enzymes Are Sufficient to Make

Aswin Thacharodi, Iain L Lamont

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pangenome analysis ofAntimicrobial agents and chemotherapy · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Mechanisms ofMedicina (Kaunas, Lithuania) · 2026
    Review
  10. Article
  11. Antibiotic resistance inFrontiers in microbiology · 2026
    Review
  12. Review
  13. Mechanistic Evaluation of LolA andInternational journal of microbiology · 2026
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Anaerobiosis and Mutations Can Reduce Susceptibility ofPathogens (Basel, Switzerland) · 2025
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Aswin ThacharodiDepartment of Biochemistry, University of Otago, Dunedin 9054, New Zealand.ORCID 0000-0003-1729-4933
Iain L LamontDepartment of Biochemistry, University of Otago, Dunedin 9054, New Zealand.ORCID 0000-0002-7601-6354
University of Otago · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aminoglycosides are widely used to treat infections of

Indexed as

amikacinaminoglycoside-modifying enzymesaminoglycoside resistanceefflux pumpsgentamicinhorizontal gene transferPseudomonas aeruginosatobramycin

Identifiers

PMID35884138
PMCPMC9312099
OpenAlexW4283788672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.